Skip to main content
Premium Trial:

Request an Annual Quote

ABI Sells DNA Analyzers to Broad Institute, Says Capillary Electrophoresis Remains Gold Standard for Sequencing

NEW YORK, June 13 (GenomeWeb News) - Applied Biosystems has sold approximately 20 capillary electrophoresis DNA sequencing instruments to the Broad Institute of MIT and Harvard, the company said today.


The purchase of the 3730xl DNA Analyzers brings the institute's number of instruments of this type to 126. The Broad plans to use the analyzers to sequence new genomes and to perform genotyping studies.


ABI interprets the sale as a sign that the days of traditional DNA sequencing are not yet numbered, despite the company's expectation that revenues from its sequencing business will decline in the future, and the Broad's purchase in March of a next-generation sequencing instrument from 454 Life Sciences.


"Broad's choice of the 3730xl instruments is confimation that capillary electrophoresis remains the gold standard in DNA analysis technology today," said CSO Dennis Gilbert in a company statement. ABI said it continues to invest in the development and enhancement of capillary electrophoresis technology.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.